CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation

Author:

Shi Hanxiao12,Niimi Atsuko1,Takeuchi Toshiyuki1,Shiogama Kazuya3,Mizutani Yasuyoshi1,Kajino Taisuke4,Inada Kenichi5,Hase Tetsunari6,Hatta Takahiro6,Shibata Hirofumi6,Fukui Takayuki7,Chen‐Yoshikawa Toyofumi Fengshi7,Nagano Kazuki8,Murate Takashi89,Kawamoto Yoshiyuki9,Tomida Shuta10,Takahashi Takashi211ORCID,Suzuki Motoshi1ORCID

Affiliation:

1. Department of Molecular Oncology School of Medicine Fujita Health University Toyoake Japan

2. Division of Molecular Carcinogenesis Nagoya University Graduate School of Medicine Nagoya Japan

3. Department of Morphology and Cell Function School of Medical Sciences Fujita Health University Toyoake Japan

4. Division of Molecular Diagnostics Aichi Cancer Center Research Institute Nagoya Japan

5. Diagnostic Pathology Bantane Hospital Fujita Health University Toyoake Japan

6. Department of Respiratory Medicine Nagoya University Graduate School of Medicine Nagoya Japan

7. Department of Thoracic Surgery Nagoya University Graduate School of Medicine Nagoya Japan

8. Department of Pathophysiological Laboratory Science Nagoya University Graduate School of Medicine Nagoya Japan

9. College of Life and Health Sciences Chubu University Kasugai Japan

10. Center for Comprehensive Genomic Medicine Okayama University Hospital Okayama Japan

11. Aichi Cancer Center Nagoya Japan

Funder

Japan Society for the Promotion of Science

Aichi Cancer Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3